Literature DB >> 21229611

P53 is transported into the nucleus via an Hsf1-dependent nuclear localization mechanism.

Qiang Li1, Jesse D Martinez.   

Abstract

Loss of p53 function can occur through disruption of its ability to localize to the nucleus. Previously we showed through characterization a set of mutant cell lines that lacked the ability to import p53 into the nucleus that nuclear translocation of p53 appeared to be mechanistically different from that of the SV40 T-antigen (SV40TAg). Here we extend that work by examining nuclear importation of p53 and SV40TAg using both in vivo and in vitro assays for nuclear localization. We show that disruption of microtubule polymerization using colchicine suppresses nuclear localization of p53 but not of SV40TAg. We also show, for the first time, that the heat shock transcription factor (Hsf1), is required for establishment of the microtubule network in cells and for nuclear localization of p53. In contrast, SV40TAg does not interact with polymerized microtubules suggesting that it is transported into the nucleus through an alternative mechanism. Interestingly, lacking of Hsf1 expression and suppressing Hsf1 by siRNA also made cells more resistant to the cytotoxic effects of paclitaxel. Hence, loss of Hsf1 activity not only suppressed p53 function, but also led to reduced sensitivity to killing by drugs that target microtubules.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21229611      PMCID: PMC3735450          DOI: 10.1002/mc.20713

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  27 in total

1.  Truncated form of importin alpha identified in breast cancer cell inhibits nuclear import of p53.

Authors:  I S Kim; D H Kim; S M Han; M U Chin; H J Nam; H P Cho; S Y Choi; B J Song; E R Kim; Y S Bae; Y H Moon
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

2.  A bipartite nuclear localization signal is required for p53 nuclear import regulated by a carboxyl-terminal domain.

Authors:  S H Liang; M F Clarke
Journal:  J Biol Chem       Date:  1999-11-12       Impact factor: 5.157

3.  Genetic analysis of p53 nuclear importation.

Authors:  Q Li; R R Falsey; S Gaitonde; V Sotello; K Kislin; J D Martinez
Journal:  Oncogene       Date:  2007-06-18       Impact factor: 9.867

4.  In vitro maintenance of highly purified, transplantable hematopoietic stem cells.

Authors:  K A Moore; H Ema; I R Lemischka
Journal:  Blood       Date:  1997-06-15       Impact factor: 22.113

5.  Conformational phenotype of p53 is linked to nuclear translocation.

Authors:  S V Gaitonde; J R Riley; D Qiao; J D Martinez
Journal:  Oncogene       Date:  2000-08-17       Impact factor: 9.867

6.  Evidence that low doses of Taxol enhance the functional transactivatory properties of p53 on p21 waf promoter in MCF-7 breast cancer cells.

Authors:  M Luisa Panno; Francesca Giordano; Fabrizia Mastroianni; Catia Morelli; Elvira Brunelli; M Grazia Palma; Michele Pellegrino; Saveria Aquila; Antonella Miglietta; Loredana Mauro; Daniela Bonofiglio; Sebastiano Andò
Journal:  FEBS Lett       Date:  2006-03-29       Impact factor: 4.124

Review 7.  Molecular chaperones and the cytoskeleton.

Authors:  P Liang; T H MacRae
Journal:  J Cell Sci       Date:  1997-07       Impact factor: 5.285

8.  Hsf1 is required for the nuclear translocation of p53 tumor suppressor.

Authors:  Qiang Li; Rebecca A Feldman; Vijayababu M Radhakrishnan; Steven Carey; Jesse D Martinez
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

9.  Mouse heat-shock factor 1 (HSF1) is involved in testicular response to genotoxic stress induced by doxorubicin.

Authors:  Pierre A Salmand; Thomas Jungas; Marylise Fernandez; Annie Conter; Elisabeth S Christians
Journal:  Biol Reprod       Date:  2008-08-13       Impact factor: 4.285

Review 10.  Heat shock response modulators as therapeutic tools for diseases of protein conformation.

Authors:  Sandy D Westerheide; Richard I Morimoto
Journal:  J Biol Chem       Date:  2005-08-01       Impact factor: 5.486

View more
  7 in total

1.  Assessment of the DNA damaging potential of environmental chemicals using a quantitative high-throughput screening approach to measure p53 activation.

Authors:  Kristine L Witt; Jui-Hua Hsieh; Stephanie L Smith-Roe; Menghang Xia; Ruili Huang; Jinghua Zhao; Scott S Auerbach; Junguk Hur; Raymond R Tice
Journal:  Environ Mol Mutagen       Date:  2017-07-17       Impact factor: 3.216

Review 2.  Uterine fibroids and current clinical challenges.

Authors:  Salama S Salama; Gökhan S Kılıç
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-03-01

Review 3.  Circadian adaptation to cell injury stresses: a crucial interplay of BMAL1 and HSF1.

Authors:  Teruya Tamaru; Masaaki Ikeda
Journal:  J Physiol Sci       Date:  2016-02-24       Impact factor: 2.781

Review 4.  Interplay between HSF1 and p53 signaling pathways in cancer initiation and progression: non-oncogene and oncogene addiction.

Authors:  Agnieszka Toma-Jonik; Natalia Vydra; Patryk Janus; Wiesława Widłak
Journal:  Cell Oncol (Dordr)       Date:  2019-06-10       Impact factor: 6.730

Review 5.  Activating p53 function by targeting RLIP.

Authors:  Sharad S Singhal; David Horne; Jyotsana Singhal; Sanjay Awasthi; Ravi Salgia
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2021-01-15       Impact factor: 11.414

6.  Rlip depletion prevents spontaneous neoplasia in TP53 null mice.

Authors:  Sanjay Awasthi; Joshua Tompkins; Jyotsana Singhal; Arthur D Riggs; Sushma Yadav; Xiwei Wu; Sharda Singh; Charles Warden; Zheng Liu; Jinhui Wang; Thomas P Slavin; Jeffrey N Weitzel; Yate-Ching Yuan; Meenakshi Awasthi; Satish K Srivastava; Yogesh C Awasthi; Sharad S Singhal
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-23       Impact factor: 11.205

Review 7.  Pleiotropic role of HSF1 in neoplastic transformation.

Authors:  Natalia Vydra; Agnieszka Toma; Wieslawa Widlak
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.